Multiple Manufacturers

RAPIVAB

Manufacturer:

Multiple Manufacturers

Rapivab HCPCS:

J2547

HCPCS Code Descriptor:

Injection, peramivir, 1 mg

Category:

J Code

Rapivab NDCs:

61364-0181-03, 72769-0181-03

Primary Type:

Antiviral

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

61364-0181-03, 72769-0181-03

About Rapivab:

RAPIVAB is an Antiviral drug manufactured by Seqirus and administered via the Intravenous route of administration. The J Code: J2547 is aligned to the drug RAPIVAB.

ACCESS PRICING AND MORE BY REGISTERING

J2547 Added Date:

January 1, 2016

J2547 Effective Date:

January 1, 2016

J2547 Termination Date:

HCPCS Active

Rapivab billing and coding information can be found through Seqirus at the link below:
Our team did not identify a source for Rapivab patient assistance information. Please reach out to our team if you feel that this is a mistake.
RAPIVAB prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for RAPIVAB. Please check back in a few weeks.